The bacterial cell wall and the enzymes that synthesize it are targets of glycopeptide antibiotics (vancomycins and teicoplanins) and β-lactams (penicillins and cephalosporins). Biosynthesis of cell wall peptidoglycan requires a crosslinking of peptidyl moieties on adjacent glycan strands. The D-alanine-D-alanine transpeptidase, which catalyzes this crosslinking, is the target of β-lactam antibiotics. Glycopeptides, in contrast, do not inhibit an enzyme, but bind directly to D-alanine-D-alanine and prevent subsequent crosslinking by the transpeptidase. Clinical resistance to vancomycin in enterococcal pathogens has been traced to altered ligases producing D-alanine-D-lactate rather than D-alanine-D-alanine. 
Introduction
Bacterial cell wall biosynthesis has been an attractive target for antibacterial drugs, including the vancomycin family of glycopeptide antibiotics and both the penicillin and cephalosporin families of β-lactam antibiotics. Both of these classes of antibiotics interdict the processing of peptidoglycan (PG) intermediates bearing D-alanine-D-alanine termini. The covalent crosslinking of adjacent peptide strands in the PG layer provides mechanical strength to the cell wall. The transpeptidase activity of bifunctional transglycosylase/transpeptidase enzymes makes the crosslinks with displacement of the terminal D-alanine. β-Lactams inhibit the activity of the transpeptidases [1, 2] , whereas vancomycins bind to the D-alanine-D-alanine PG termini to block transpeptidase action [3] . Both drugs lead to decreased crosslinking as the molecular basis of their antibacterial activity. [4] . The Ddl group of enzymes are of special interest for two reasons. First, they are themselves targets for antibiotics, although only D-cycloserine has been developed for human use. Second, variants of the Ddls are the agents of peptidoglycan remodeling in the three major clinical phenotypes of vancomycin-resistant enterococci (VRE). In the VanA (resistant to vancomycin and teicoplanin) and VanB (resistant to vancomycin but susceptible to teicoplanin) phenotypes the PG termini are D-alanine-D-lactate, which has an ester instead of an amide linkage, whereas in VanC the replacement is to a D-alanine-D-serine [5] . The VanC-type D-alanine-D-serine terminus has a tenfold reduced affinity for vancomycin, the VanA-type and VanB-type depsipeptide terminus has a much higher 1000-fold reduction of affinity.
In a real sense, therefore, vancomycin resistance in VRE is caused by a switch of D-alanine-D-alanine to D-alanine-D-X ligases (where X is any amino acid) and the ability of the VanA and VanB ligases to make depsipeptide is a true gain of function, which involves the selective activation of the 2-OH of D-lactate as a nucleophile towards D-alanine-OPO3 2- (Figure 1 ).
When Ddls are compared with VanA, B and C by homology searches, five subfamilies can be distinguished [6, 7] . There are two Ddl subfamilies (DdlA and DdlB), a VanCtype D-alanine-D-serine ligase subfamily and the two clusters of D-alanine-D-lactate ligases. One D-alanine-D-lactate subfamily is represented by the VanA and VanB ligases, as well as the depsipeptide ligases of the vancomycin producers [8] . The second D-alanine-D-lactate ligase subfamily is found in the lactic acid bacteria, soil organisms with natural resistance to vancomycin producers. This group includes Leuconostoc mesenteroides [9] , from which we have previously purified the LmDdl2 ligase [10] and proved its depsipeptide activity.
Deciphering the molecular basis of alanine-alanine versus alanine-lactate production by the ligase subfamilies will require three-dimensional structures of complexes with substrates or inhibitors. The first picture of a D-alanine-D-alanine ligase emerged with the X-ray structure for the Escherichia coli DdlB in complex with ADP and a tetrahedral analog of the reaction intermediate [11] . Among the findings from that work were the identification of an omega loop closed over the intermediates and a hydrogen-bonding network involving Tyr216 on that loop. The Tyr216→Phe mutant was observed to have a small but detectable gain of D-alanine-D-lactate depsipeptide ligase activity, approximately 40-fold greater in catalytic efficiency than the wild-type DdlB, perhaps reflecting an initial step along the path to an efficient depsipeptide ligase [12] . Relative to DdlB, both of the alanine-lactate ligase subfamilies have substantially higher ratios of alanine-lactate/alanine-alanine activity ( Table 1 ). The LmDdl2 ligase shows a ratio of 3000:1, whereas the VanA ligase is tenfold better with a ratio of 30,000:1. In an effort to understand these variations in function, we report here the structure of a ligase from the second depsipeptide ligase subfamily, the LmDdl2 ligase from the vancomycin-resistant organism L. mesenteroides. Now available are crystal structures of three D-alanine-D-X ligases, and a fourth is under investigation [13] . Each ligase varies greatly in its production of depsipeptide (Table 1) , and thereby provides very different levels of resistance to antibiotics of the glycopeptide family, ranging from no resistance in wild-type organisms with the DdlB-type ligase, through mid-level resistance in organisms such as L. mesenteroides with the LmDdl2 ligase, to high-level resistance in enterococcal pathogens using the VanA ligase. In the crystal structures [11, 14] , all ligases are complexed with similar dipeptidyl analogs of known properties and kinetics [10, 15, 16] , so that comparison of binding sites might explain the subtle differences in ligand specificities. Here we focus on a comparison of the LmDdl2 and DdlB ligases, with a brief inclusion of the recently established VanA structure (D Roper and G Dodson, unpublished observations).
Results and discussion
Crystal structure of the LmDdl2 ligase LmDdl2 ligase is dimeric in the crystal (Figure 2a ) as well as in solution [10] , with a noncrystallographic diad near residues Ile85, Leu114, Leu127, Val132 and Leu142, most of which are on α helices forming a hydrophobic interface. LmDdl2 comprises three α + β domains (Figure 2b ), a folding motif first seen in glutathione synthetase [17, 18] . The amide bond-forming site lies generally at the intersection of all three domains. The ATP-binding site is between two antiparallel β sheets of the central and C-terminal domains and has the so-called 'palmate' [17] or 'grasp' [19] motif now seen in other ATP-dependent enzymes [20, 21] .
Comparison of ligase foldings
Global similarity of the LmDdl2 and DdlB D-alanine-D-X ligases is apparent in Figure 2b . LmDdl2 (and VanA) contain a large 36-residue insertion in the N-terminal domain that is not present in the smaller E. coli DdlB enzyme ( Figure 3 ). This insertion is unlikely to have an influence on ligand specificity, however, as it is located on the surface about 20 Å distant from the binding site for the second ligand (subsite 2). The LmDdl2 ligase, the largest of the three ligases, has a five-residue insertion in the omega loop at position 247. LmDdl2 also has a much longer C-terminal peptide that extends in the direction of the other monomer in the dimer (Figure 2a ). About half of this 20-residue C-terminal extension is seen in the electron-density map, and the invisible half is possibly near the omega loop of the other monomer. C-terminal disorder might be required for the movement of the omega loop, which must open and close for ligand entry and exit for each cycle of catalysis [22] . Consistent with this idea is the finding that the more disordered C terminus of monomer 1 lies near the disordered omega loop of ligand-less monomer 2. This disorder might be the cause of the high mosaicity that is observed in crystals.
With the LmDdl2 and DdlB sequences aligned according to the crystallographic alignment in Figure 3 , their similarity is 44%. For the calculation of the root mean square deviation (rmsd) of the two structures, 16 common residues surrounding the ATP and ligand-binding sites were chosen as a core set. The Cα atoms of the core residues overlay rather closely (0.73 Å). When adding the This figure was created using RIBBONS [41] .
Figure 3
Amino acid sequences of the D-alanine-Dalanine ligase from the ddlB gene of E. coli [42] (top) and the D-alanine-D-lactate ligase from the lmddl2 gene of L. mesenteroides [43] . Boxes contain segments clearly matched by overlay of crystallographic structures. Important spatially equivalent core residues in DdlB/LmDdl2 are: Glu15/Glu16, His63/His102, Lys97/Lys136, Lys144/Lys180, Ser150/Ser186, Ser151/Ser187, Glu180/Glu216, Lys181CO/Glu217CO, Glu187/Glu224, Arg255/Arg301, Asp257/Asp303, Glu270/Glu316, Asn272/Asn318, Gly276/Gly322, Ser281/Ser327 and Leu282/Leu328. The α and β secondary structures are indicated by boxes and arrows, respectively. Cα atoms of all aligned residues (as defined in Figure 3 ) to the core Cα atoms the rmsd increases to 1.4 Å. The phosphinophosphate analog 2 2 is known [23, 24] to inhibit wild-type Ddls with a very long half-life (in the order of days). Its inhibitory effect on the VanA depsipeptide ligase is much less striking [16] . For the LmDdl2 ligase, the inhibition level is unmeasured but thought to be poor, and capture of 2 2 in a crystal structure was not assured. In fact, we find that only one monomer of the LmDdl2 dimer contains the analog, and there is disorder around the empty binding site of the second monomer.
In the ordered monomer, the omega loop and a smaller serine-serine loop (185-188) close over the cavity holding ADP and 2 2. A hydrogen bond from Ser187 in the serine loop to the backbone CO of Tyr255 in the omega loop is maintained in all ligases (Table 2 and Figure 6 ). Because a second hydrogen bond linking the two loops in DdlB is absent in this LmDdl2 enzyme, where Phe261 replaces Tyr216, one would expect that these loops might be more 'floppy' than in the DdlB enzyme. But this LmDdl2 structure and the structure of the Tyr216→Phe mutant of DdlB [14] show that there is insignificant increase in loop movement and indicate that the OH group is not required for loop closure.
Binding sites for ADP and D-alanyl phosphate
The geometry for ATP and D-alanine 1 substrates in LmDdl2 is similar to that in DdlB [11] . The adenine group of the nucleotide is in a hydrophobic area with its amine group hydrogen bonded to a sidechain of a conserved glutamic acid (Glu216) and a backbone carbonyl group (Glu217). The hydroxyl groups of the ribose hydrogen bond with Glu224, and conserved lysines Lys136 and Lys180 interact with the α-and β-phosphate groups of ADP. The ammonium group of a lysine on the omega loop (Lys260) joins two magnesium cations in bridging the β-and γ-phosphate groups. In VanA, however, this omega-loop lysine residue is absent and
Figure 4
Co-crystallization of phosphinate 1 with the LmDdl2 ligase and ATP produced ADP and the transition-state analogue 2.
Figure 5
The 2F o -F c electron-density map of ADP, phosphorylated phosphinate 2 and bridging magnesium ions in monomer 1 at a contour level of 0.9σ. This figure was created using CHAIN [36] . The α-ammonium group of the phosphorylated D-alanine 1 is hydrogen bonded to the carboxylate group of the strictly conserved Glu16 (Table 2 and Figure 6 ). Polarization of the terminal P-O bond in the intermediate is accomplished by hydrogen bonds from the sidechain amide of conserved Arg301 and the backbone amide of Gly322 in an oxyanion hole. Placement of the D-methyl group near Val19 and the face of His102 helps define substrate chirality.
Specificity for the second ligand
The D-alanine-D-X ligases must have the architecture necessary to discriminate between zwitterionic D-alanine 2 [7, 25] and anionic D-lactate competing for subsite 2. Can we explain why, in the LmDdl2 ligase, the binding affinity of D-lactate is tenfold higher than that of D-alanine 2 [10] , and that D-lactate readily ligates with the activated D-alanine 1 even though D-lactate is a weaker nucleophile than D-alanine 2 ?
We first address the greater affinity of subsite 2 for D-lactate over D-alanine. External to the site is a positive sidechain, Arg22 (Lys22 in VanA), which would be better than the neutral Asn21 in DdlB in attracting the anionic lactate. Internal groups surrounding subsite 2 include the conserved residues Val19, Thr324 and Leu328. But two changes in LmDdl2 will alter the hydrophobicity and size of subsite 2 relative to DdlB ligase. Firstly, a buried Met326 is found in van der Waals contact with the second ligand, replacing a solvent-exposed His280 in DdlB (Figure 7 ). The -CH2-S-CH3 portion of Met326 will fill 55-60 Å 3 [26] of the binding cavity and could restrict the binding of the zwitterionic amino acid [25] in favor of the slightly smaller lactate anion. (The NH 3 + and OH groups are estimated to differ in volume by 10-12 Å 3 ). And secondly, Tyr216 in DdlB is replaced by the more hydrophobic Phe261 in LmDdl2. Together, these alterations in cavity size and hydrophobicity might contribute to the tenfold greater binding for lactate over alanine 2 in LmDdl2. Opposing this trend, however, is the fact that the hydrophobic sidechain of Leu328, although it is common to LmDdl2 and DdlB, has rotated approximately 3 Å away from the C-terminal carboxylate, having been replaced by a water molecule.
In searching for enzymic influences on the nucleophilicity of the second ligand, we see that the local binding interactions of the C terminus of the analog indeed differ from those observed in DdlB (Table 2, Figures 6,7) . Subsite 2 lies at the N terminus of the 327-335 helix, the dipole of which might assist alignment of the ligand [11] . Unlike the situation in the DdlB complex, however, in LmDdl2 the secondary structure of this helix is somewhat irregular. The carboxylic acid group of 2 2 is not as strongly hydrogen bonded to the hydroxyl group of conserved Ser327, and, significantly, no carboxylate hydrogen bond exists to the backbone amide of Leu328. Structurally, the longer distances in LmDdl2 result from an expansion of the ligation site along the dipeptide axis. Thus, distances from Glu16 or Ser186 (residues near the N-terminal alanine 1 ) to Ser327 or Leu328 (residues near the C-terminal ligand) are longer in LmDdl2 by 0.5-1.4 Å. Given the prepositioning of the N-terminal D-alanine 1 , the C-terminal carboxylic acid group of the second ligand falls short of one of the two potential hydrogen-bonding groups on the enzyme. Instead, a water molecule bridges between a carboxylate oxygen atom and the backbone amide of Leu328. For an incoming lactate molecule, therefore, weaker hydrogen bonding by its carboxylate group would increase the nucleophilicity of the α-hydroxyl group, and hence facilitate its attack on the activated carbon of alanine 1 in the first site.
Catalytic residues?
A plausible catalytic base was never identified in the DdlB ligase [11, 15] . Based on the crystal structure, the Figure 6 .
Figure 6
Schematic showing the distances listed in Table 2 . Residues Tyr255, Lys260 and Phe261 are on the omega loop. Gly322NH and Arg301 form an oxyanion hole. Tyr216→Phe mutant of the DdlB enzyme was made and found to exhibit a small amount of new depsipeptide activity [12] ( Table 1 ). The markedly more active LmDdl2 ligase in fact contains phenylalanine (Phe261) at the corresponding spatial position (Figure 7 ), but other changes exist as well, the importance of which can be evaluated by site-directed mutagenesis. For example, a buried glutamic acid Glu226 in LmDdl2 has replaced a threonine in DdlB. Glu226 reaches toward the analog 2 2, forming a weak water-bridged hydrogen bond with the acyl phosphate group and another with the C-terminal carboxylate group of 2 2. Within 2.7 Å of Glu226 is a buried histidine residue, His243. Although the catalytic involvement of this histidine is unknown, it is interesting that the histidine-glutamate pair is only found in the ligase with moderate depsipeptide activity. The inactive DdlB ligase, its weakly acitve Tyr216→Phe mutant, and the highly active VanA ligase all have unreactive residues at these two positions. The recent crystal structure of VanA (D Roper and G Dodson, unpublished observations) shows that a much better-positioned histidine His244 replaces Phe216 of DdlB and Phe261 of LmDdl2, an alignment unforeseen in earlier sequence matches [7, 11] .
Biological implications
Bacteria are rapidly changing in response to heavy antibiotic use, either by means of microbial selection, mutations, or transfer of genetic material from drug-resistant strains to susceptible strains [27] . The steady spread of resistance to the penicillins is well documented [28] . Vancomycin, the backup antibiotic for Gram-positive infections that do not respond to penicillin therapy, is increasingly used in the treatment of methicillin-resistant Staphylococcus aureus. With the discovery of vancomycin resistance in Enterococcus faecium in 1988, there is growing concern that the plasmid-borne resistance will be transferred to Staphylococcus aureus [29, 30] . 
Materials and methods

Strains and chemicals
E. coli strains BL2(DE3) and B834(DE3) were obtained from Novagen (Madison, WI). Culture media was obtained from Difco Laboratories (Detroit, MI). Amino acids, nucleotides, dithiothreitol (DTT), ampicillin, and buffers were from Sigma Chemical Co. (St. Louis, MO). Isopropyl-thio-β-D-galactoside (IPTG) was purchased from Bachem Biosciences (Torrance, CA) and polyethyleneglycols (PEGs) were from Hampton Research (LaGuna Niguel, CA). Phosphinate 1 was a generous gift from PA Bartlett and BA Ellsworth (University of California, Berkeley).
Overexpression of wild-type and selenomethionine LmDdl2
LmDdl2 ligase was overexpressed as described previously [10] . For overexpression of the selenomethionine-substituted LmDdl2 ligase, pLmDdl2 was transformed into the E. coli met auxotroph expression strain B834(DE3). The corresponding strain was grown overnight in 21 ml of medium, which was 5% (v:v) Luria broth and 95% M9 medium supplemented with 1 mg l -1 thiamine, 1 g l -1 glucose, 489 mg l -1 MgSO 4 .7H 2 O, 14.7 mg l -1 CaCl 2 , 7.5 mg l -1 FeSO 4 , 100 µg l -1 ampicillin, 50 mg l -1 each of 18 amino acids (excluding methionine and cysteine), and 50 mg l -1 selenomethionine [32] . The cells were spun down, resuspended in M9 media (supplemented as above), and used to inoculate 2 l of supplemented M9 media. The culture media was incubated at 37°C until A 595 = 0.8. IPTG at a final concentration of 0.5 mM was added to induce lmddl2 gene expression, and the culture was further incubated for 5 h at 30°C.
Figure 7
Overlay of phosphorylated phosphinate 2 in the binding site in LmDdl2 (red) and DdlB (orange). LmDdl2 residues are numbered. Distances are given in Table 2 . This figure was drawn using MOLSCRIPT [44] . 
Protein purification
Purification of wild-type LmDdl2 ligase was performed as previously described [10] . Selenomethionine LmDdl2 was purified similarly except that degassed 50 mM HEPES at pH 7.2, 5 mM MgCl 2 , 1 mM EDTA, 200 mM KCl, and 1 mM DTT was used for cell lysis and subsequent purification steps, yielding 60 mg of purified protein.
Mass spectrometry analysis
Wild-type and selenomethionine LmDdl2 were analyzed by electrospray mass spectrometry at the Mass Spectrometry Facility of Harvard University (Cambridge, MA). For wild-type LmDdl2, which contains six methionine residues in a total of 377, the measured mass is 41,686 Da. The measured mass for selenomethionine LmDdl2 is 41,947 Da. The 261 mass difference is between that expected for five and six selenium substitutions per molecule.
Crystallization
Both wild-type and selenomethionine-substituted LmDdl2 protein could be crystallized under similar conditions. Crystals were grown at room temperature by the vapor equilibrium method. The drop contained protein at 3.5 mg ml -1 in 15% PEG 8000 (or mPEG 5000) for the selenoprotein), 0.1 M ammonium sulfate, 50 mM NaCl (0 mM for selenoprotein), 2.4 mM DTT for selenoprotein, 1 mM MgCl 2 , 3 mM ATP (AMP-PNP for the selenoprotein), 3 mM phosphinate, in 50 mM MES buffer at pH 6.5. The reservoir contained 30% PEG or mPEG and 0.2 M ammonium sulfate in 0.1 M MES buffer. Diamond-shaped plates appeared after one to two weeks. Separation of glycol and salt phases occurred in most drops after one month. Two monoclinic forms grew under these conditions. Form 1, the subject of this paper, had unit-cell dimensions 118. 
X-ray data from the native LmDdl2 crystal
A form 1 crystal was immersed in the 30% PEG holding solution containing 25% MPD for 4 min prior to being loop-mounted and flash cooled to 100°K in a liquid nitrogen gas stream. Single-wavelength (0.908 Å) data collection was performed at MacCHESS station A1 at the Cornell High Energy Synchrotron Source, Ithaca, NY. A CCD area detector (Area Detector Systems Corp.) was used in 1k × 1k mode at a distance of 80 mm from the crystal. A total of 204° of data, made from 1° phi oscillations of 20 sec each, was processed using the HKL programs [33] . Calculated mosaicity was high (1.9°) and overall completeness was only 82% to 2.38 Å resolution. The R merge (on intensities) was 7.2% (Table 3) .
X-ray data from the selenomethionine LmDdl2 crystal
A form 1 seleno-crystal was immersed in the PEG holding solution containing 22% MPD for 45 sec and flash cooled to 100°K in a liquid nitrogen gas stream. MAD data were collected by the reverse-beam method at three wavelengths (0.9500 Å remote, 0.9786 Å peak and 0.9789 Å edge) at station ×12c at NSLS at Brookhaven National Laboratory. A CCD area detector (Brandeis B4) 344 mm from the crystal recorded 2k × 2k images for a 1° phi oscillation. Count times were 50 sec per image. Data were collected at the edge wavelength over a 36° wedge of phi, then recollected at the peak and remote wavelengths until 107°o f data were recorded. This process was repeated at phi plus 180°. Intensities were indexed and scaled by HKL [33] . Poor crystal mosaicity (0.8°) reduced the completeness of the three data sets to 55-63% at 2.4 Å resolution. R merge values were 4.8%, 5.8% and 5.2% at the three wavelengths (Table 3) .
Structure solution
A search for a molecular replacement solution using DdlB structures (2DLN, 1IOV or 1IOW) as models was not successful. In spite of poor data completeness for the selenomethionine crystal, the structure was determined by the MAD method using version 1.15 of the program SOLVE [34] . The Patterson analysis found 10 of the 12 possible selenium atoms (11 expected from mass spectrometry). The average selenium occupancy and B factor were 0.95 and 43 Å 2 , respectively. The successful heavy-atom solution had a Z-score of 76.3. The resulting electron-density map at 2.5 Å resolution had a standard deviation in the local rms density equal 0.34, and the correlation of rms density in neighboring regions was 0.40. The unmodified MAD-phased map was much better than an earlier three-derivative multiple isomorphous replacement (MIR) map (figure of merit = 0.58 at 3 Å resolution). The MAD map showed 95% of the backbone chain for monomer 1 and density for its ligands, and about 90% of the chain of monomer 2. Missing in monomer 2 was density for the omega loop (245-266) near the catalytic site, possibly because of the absence of ligands in the binding site of this monomer (see below). Density-modified maps based on solvent flattening or twofold symmetry averaging were also examined, but did not improve the density of the omega loop in monomer 2. The sequence [35] of the 377-residue protein was manually fitted using the programs CHAIN [36] and FRODO [37] . The 2 molecules formed a noncrystallographic dimer (Figure 2a ) and were fitted independently.
Structure refinement
Simulated annealing refinement was initiated at 1,500 K with X-PLOR version 3.8.5.1 [38] . Data from 8.0-2.5 Å with F obs greater than 2σ(F) were used, with 4% of the data excluded for calculating R free [39] . Individual B factors were initially set to 15 Å 2 for protein atoms. Water molecules were excluded from this early refinement, as were ligands and several residues from the N and C termini of each molecule. Monomer 2 also lacked 22 residues in the omega loop. Examination of 2F o -F c and F o -F c maps of the dimer allowed the fitting of ADP and phosphinophosphate 2 in the binding site of monomer 1, but not in monomer 2. Various annealing and energy minimization protocols failed to bring up density for the ligands or omega loop of monomer 2.
Final cycles of refinement used all 2.38 Å data from the native crystal, which had better completeness in the higher resolution shells. For a model that includes 360 residues in monomer 1 (3-362), 347 residues in monomer 2 (numbered 402-644 and 667-770), one ADP and one phosphinophosphate 2 ligand in monomer 1, and 213 water molecules Research Article D-Alanine-D-lactate ligase Kuzin et al. 469 Table 3 X-ray data for native and selenomethionine crystals*. (B factors < 60 Å 2 ), the resulting crystallographic R factor is 0.184 for all F > 0 data from 100-2.38 Å (27,948). The R free value is 0.257. Deviations of the protein model from ideality are 0.008 Å and 1.4° for covalent bonds and angles, respectively. The electron density of ADP and 2 is seen in Figure 5 .
Accession numbers
Atomic coordinates have been deposited in the Protein Data Bank (with the accession code 1EHI) at Rutgers University.
